 |
|
|
|
|
|
|
|
 |
Results for 'King Pharmaceuticals Inc - Deals and Alliances Report' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
King Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
100 % |
Mylan Laboratories Inc Deals
Partneringdesk briefing
|
July 2005 |
£215 |
48 % |
Partneringdesk deals and alliances in genitourinary and gynecological diseases
|
April 2006 |
£1250 |
47 % |
King Pharmaceuticals Inc -Detailed Product Pipeline
|
February 2008 |
£375 |
37 % |
Late Stage Deals
Strategy, Structure and Payment Terms
|
August 2004 |
£950 |
37 % |
Premium Company Profile Pain Therapeutics
|
October 2007 |
£265 |
35.5 % |
Distribution Agreements in Biopharma
|
April 2008 |
£1195 |
35 % |
Co-promotion & Co-marketing Agreements in Biopharma
|
January 2008 |
£1195 |
32.9 % |
Manufacturing & Supply Agreements in Biopharma
|
April 2008 |
£1195 |
32.55 % |
Merger & Acquisition Agreements in Biopharma
|
February 2008 |
£1195 |
29.05 % |
Effectively Selling Medical Devices in Europe
|
June 2007 |
£295 |
27.5 % |
Dr Reddy Generics Company Intelligence Report
Company Intelligence Report
|
March 2008 |
£195 |
24.5 % |
Anti Infectives, Vol II: Antibacterials
|
April 2007 |
£1510 |
18.55 % |
Global Market for Sleep-Wake Disorders, 2005-2012, The
Trends, Opportunities, and Insights in a High-Value CNS Therapy Area
|
December 2005 |
£1100 |
18.55 % |
Drug Delivery Technology: Revolutionizing CNS Therapies
|
December 2007 |
£945 |
17.85 % |
2015: Strategic Considerations for the U.S. Pharmaceutical Industry
|
February 2005 |
£1810 |
17.85 % |
Fastest Growing Biotechnology Companies, The
Growth Strategies, Comparative Analyses and Company Profiles
|
March 2008 |
£1995 |
17.85 % |
Bariatric (Obesity) Care Equipment & Surgical Devices Worldwide
A Market Strategy Report
|
February 2006 |
£990 |
17 % |
Pharmaceutical Parallel Trade in the United Kingdom, 2000-2006
Market Insights and Trends in a Primary Import Destination
|
August 2006 |
£900 |
16 % |
Global Market for Antimicrobials and Antifungals; The
Challenging Resistance to 2016
|
December 2006 |
£1600 |
15.75 % |
World Generic Market Report 2007
|
November 2006 |
£595 |
15.05 % |
Generic League
Market Analysis and Forecasts, 2007-2012, 2017 & 2022
|
February 2008 |
£1999 |
10.5 % |
Antiageing and Life Enhancement Pharmacotherapeutics
|
January 2006 |
£4600 |
7 % |
GSK's Cervarix
A Future Blockbuster of 2007
|
March 2007 |
£1999 |
5.95 % |
|
|
|
|
